MedPath
NMPA Approval

Neostigmine Methylsulfate Injection

国药准字H20249341

November 15, 2024

Drug Information

甲硫酸新斯的明注射液

注射剂

4ml:2mg

化学药品

November 15, 2024

Company Information

Applicant Company

安徽省合肥市经开区文山路与繁华大道交口

Manufacturing Company

安徽省合肥市经开区文山路与繁华大道交口

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲硫酸新斯的明注射液 - NMPA 批准文号 | MedPath